These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15712344)

  • 21. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
    Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N
    Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PIK3CA gene mutations in pediatric and adult glioblastoma multiforme.
    Gallia GL; Rand V; Siu IM; Eberhart CG; James CD; Marie SK; Oba-Shinjo SM; Carlotti CG; Caballero OL; Simpson AJ; Brock MV; Massion PP; Carson BS; Riggins GJ
    Mol Cancer Res; 2006 Oct; 4(10):709-14. PubMed ID: 17050665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PIK3CA, HRAS and KRAS gene mutations in human penile cancer.
    Andersson P; Kolaric A; Windahl T; Kirrander P; Söderkvist P; Karlsson MG
    J Urol; 2008 May; 179(5):2030-4. PubMed ID: 18355852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas.
    McConechy MK; Anglesio MS; Kalloger SE; Yang W; Senz J; Chow C; Heravi-Moussavi A; Morin GB; Mes-Masson AM; ; Carey MS; McAlpine JN; Kwon JS; Prentice LM; Boyd N; Shah SP; Gilks CB; Huntsman DG
    J Pathol; 2011 Apr; 223(5):567-73. PubMed ID: 21381030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of hotspot mutations in exons 9 and 20 of the PIK3CA gene in human oral squamous cell carcinoma in the Greek population.
    Kostakis GC; Papadogeorgakis N; Koumaki V; Kamakari S; Koumaki D; Alexandridis C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):e53-8. PubMed ID: 20416519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
    Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
    Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PIK3CA gene mutations and amplifications in Chinese patients with ovarian clear cell carcinoma.
    Jiang G; Huang Z; Zhang S; Wang L
    Cancer Invest; 2013 Dec; 31(10):639-44. PubMed ID: 24299208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PIK3CA mutations in breast cancer are associated with poor outcome.
    Li SY; Rong M; Grieu F; Iacopetta B
    Breast Cancer Res Treat; 2006 Mar; 96(1):91-5. PubMed ID: 16317585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation of PIK3CA: possible risk factor for cervical carcinogenesis in older women.
    Cui B; Zheng B; Zhang X; Stendahl U; Andersson S; Wallin KL
    Int J Oncol; 2009 Feb; 34(2):409-16. PubMed ID: 19148475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
    Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J
    Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients.
    Lai YL; Mau BL; Cheng WH; Chen HM; Chiu HH; Tzen CY
    Ann Surg Oncol; 2008 Apr; 15(4):1064-9. PubMed ID: 18183466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucinous breast carcinomas lack PIK3CA and AKT1 mutations.
    Kehr EL; Jorns JM; Ang D; Warrick A; Neff T; Degnin M; Lewis R; Beadling C; Corless CL; Troxell ML
    Hum Pathol; 2012 Dec; 43(12):2207-12. PubMed ID: 22705004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients.
    Tanaka Y; Kanai F; Tada M; Asaoka Y; Guleng B; Jazag A; Ohta M; Ikenoue T; Tateishi K; Obi S; Kawabe T; Yokosuka O; Omata M
    Oncogene; 2006 May; 25(20):2950-2. PubMed ID: 16331247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations of the PIK3CA gene in diffuse large B cell lymphoma.
    Baohua Y; Xiaoyan Z; Tiecheng Z; Tao Q; Daren S
    Diagn Mol Pathol; 2008 Sep; 17(3):159-65. PubMed ID: 18382359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare mutations of the PIK3CA gene in malignancies of the hematopoietic system as well as endometrium, ovary, prostate and osteosarcomas, and discovery of a PIK3CA pseudogene.
    Müller CI; Miller CW; Hofmann WK; Gross ME; Walsh CS; Kawamata N; Luong QT; Koeffler HP
    Leuk Res; 2007 Jan; 31(1):27-32. PubMed ID: 16764926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses.
    Hafner C; Vogt T; Landthaler M; Müsebeck J
    Br J Dermatol; 2008 Jul; 159(1):214-7. PubMed ID: 18503601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of p53 mutation in the carcinomas arising from endometriosis.
    Akahane T; Sekizawa A; Purwosunu Y; Nagatsuka M; Okai T
    Int J Gynecol Pathol; 2007 Jul; 26(3):345-51. PubMed ID: 17581423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian cancer is a heterogeneous disease.
    Wang V; Li C; Lin M; Welch W; Bell D; Wong YF; Berkowitz R; Mok SC; Bandera CA
    Cancer Genet Cytogenet; 2005 Sep; 161(2):170-3. PubMed ID: 16102589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of decreased mitochondrial DNA content with ovarian cancer progression.
    Wang Y; Liu VW; Xue WC; Cheung AN; Ngan HY
    Br J Cancer; 2006 Oct; 95(8):1087-91. PubMed ID: 17047655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Geographical variations in TP53 mutational spectrum in ovarian carcinomas.
    Dansonka-Mieszkowska A; Ludwig AH; Kraszewska E; Kupryjańczyk J
    Ann Hum Genet; 2006 Sep; 70(Pt 5):594-604. PubMed ID: 16907706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.